get a key
steadybase-$ company SLGL
account_id none on file
legal_name Sol-Gel Technologies Ltd.
ticker SLGL
cik 1684693
domain sol-gel.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 0 filings 6 executives 0 family 0
why_nownone on file
callsnone on file
filings
The CRO contracts generally include pass-through fees including, but not limited to, regulatory expenses, investigator fees, travel costs

filing / Mar 19, 2026 / receipt

In addition to continuing pressure on prices and cost containment measures, legislative developments at the EU or member state level may result in significant additional requirements or obstacles that may increase our operating costs.

filing / Mar 19, 2026 / receipt

Cost reduction initiatives and changes in coverage implemented through legislation or regulation could decrease utilization of and reimbursement for any approved products we may market in the future.

filing / Mar 19, 2026 / receipt

set aside or accrued to provide pension, severance, retirement or similar benefits or expenses, but does not include business travel,

filing / Mar 19, 2026 / receipt

In June 2023, the Company signed an extension to the office lease agreement, for the period starting January 1, 2024 for an additional period of two years, with an option to extend the agreement for another two years, meaning a maximum extension period of four years.

filing / Mar 19, 2026 / receipt

In July 2025, the Company signed an extension to the office lease agreement for two years. These agreements are classified as operating leases and are presented under operating lease right-of-use assets and operating leases liabilities.

filing / Mar 19, 2026 / receipt

executivesnone on file
familynone on file
upcoming
2026-11-19 earnings call scheduled ir
changesnone on file
mcp_package_hint
steadybase-$